Download PDF
Facial Plast Surg 2019; 35(03): 224-229
DOI: 10.1055/s-0039-1688843
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Overview of Deep Dermal Fillers

Michael H. Liu
1   Department of Dermatology, University of California Los Angeles, Los Angeles, California
,
David P. Beynet
1   Department of Dermatology, University of California Los Angeles, Los Angeles, California
2   Department of Dermatology, VA Greater Los Angeles Healthcare System, Los Angeles, California
,
Nima M. Gharavi
3   Department of Dermatology, Cedars-Sinai Medical Center, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
12 June 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Dermal fillers have become an integral part of both medical and cosmetic dermatology. Our expanding knowledge of the aging face has allowed us to shift the focus from skin-reduction lifting procedures to soft tissue augmentation. Within the past 5 years alone, nine new dermal fillers have been approved by the U.S. Food and Drug Administration for soft tissue augmentation. The rise in both the use and number of dermal fillers in recent years is a testament to their safety and efficacy. Dermal fillers can be broken down to three major types: temporary, semipermanent, and permanent. The former, which include hyaluronic acid based fillers, provide safe and effective correction but only for a limited time, typically approximately 1 to 2 years at best. This review will cover the semipermanent (poly-L-lactic acid and calcium hydroxylapatite) and permanent (polymethylmethacrylate and liquid silicone) injectable fillers. These so-called deep dermal fillers are valuable, durable tools in correcting the aging face. Given their extended duration of effect, these fillers inherently carry their own risk for potential adverse events. Thus, it is essential that clinicians have a thorough understanding of these products to best counsel, recommend, and perform soft tissue augmentation using these fillers.

Keywords

filler - soft tissue augmentation - semipermanent filler - permanent filler - rejuvenation

Supplementary Material

 

  • References

  • 1 Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg 2006; 118 (3, Suppl): 7S-14S
    CrossrefPubMedGoogle Scholar
  • 2 Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118 (3, Suppl): 55S-63S
    CrossrefPubMedGoogle Scholar
  • 3 Klein AW, Elson MLJDS. The history of substances for soft tissue augmentation. Dermatol Surg 2000; 26 (12) 1096-1105
    CrossrefPubMedGoogle Scholar
  • 4 Jones DH. Semipermanent and permanent injectable fillers. Dermatol Clin 2009; 27 (04) 433-444 , vi
    CrossrefPubMedGoogle Scholar
  • 5 Alam M, Tung R. Injection technique in neurotoxins and fillers: indications, products, and outcomes. J Am Acad Dermatol 2018; 79 (03) 423-435
    CrossrefPubMedGoogle Scholar
  • 6 Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol 2004; 3 (05) 542-547
    PubMedGoogle Scholar
  • 7 Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003; 27 (05) 354-366 , discussion 367
    CrossrefPubMedGoogle Scholar
  • 8 Valantin M-A, Aubron-Olivier C, Ghosn J. , et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003; 17 (17) 2471-2477
    CrossrefPubMedGoogle Scholar
  • 9 Galderma Laboratories. Sculptra Aesthetic injectable poly-L-lactic acid. Instructions for Use. Available at: https://www.galderma.com/us/sites/g/files/jcdfhc341/files/2019-01/Sculptra_Aesthetic_IFU.pdf?_ga=2.112146628.1576575081.1551360421-1559681121.1551360421 . Accessed January 20, 2019
  • 10 Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg 2006; 118 (3, Suppl): 46S-54S
    CrossrefPubMedGoogle Scholar
  • 11 Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging 2008; 3 (01) 161-174
    CrossrefPubMedGoogle Scholar
  • 12 Merz. Radiesse Injectable Implant. Instructions for Use. Available at: https://www.radiesse.com/wp-content/uploads/RadiessePlus-IFU.pdf . Accessed January 20, 2019
    PubMed
  • 13 Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 2004; 6 (04) 223-226
    CrossrefPubMedGoogle Scholar
  • 14 Carruthers A, Carruthers J. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus. Dermatol Surg 2008; 34 (11) 1486-1499
    PubMedGoogle Scholar
  • 15 Zide BM. Radiance Short-term experience. Aesthet Surg J 2003; 23 (06) 495-499
    CrossrefPubMedGoogle Scholar
  • 16 Lemperle G, Knapp TR, Sadick NS, Lemperle SM. ArteFill permanent injectable for soft tissue augmentation: I. Mechanism of action and injection techniques. Aesthetic Plast Surg 2010; 34 (03) 264-272
    CrossrefPubMedGoogle Scholar
  • 17 Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg 2009; 123 (06) 1842-1863
    CrossrefPubMedGoogle Scholar
  • 18 Galderma Laboratories. Bellafill Skin Test Instructions for Use. Available at: https://bellafill.com/wp-content/uploads/2018/12/7254Rev00_Bellafill-Skin-Test_e-IFU_CANADA-EN.pdf . Accessed January 20, 2019
  • 19 Galderma Laboratories. Bellafill Instructions for Use. Available at: https://bellafill.com/wp-content/uploads/2018/12/7251Rev00_Bellafill_e-IFU_US.pdf . Accessed January 20, 2019
  • 20 Joseph JH, Eaton LL, Cohen SR. Current concepts in the use of Bellafill. Plast Reconstr Surg 2015; 136 (5, Suppl): 171S-179S
    CrossrefPubMedGoogle Scholar
  • 21 Gold MH, Sadick NS. Optimizing outcomes with polymethylmethacrylate fillers. J Cosmet Dermatol 2018; 17 (03) 298-304
    CrossrefPubMedGoogle Scholar
  • 22 Rohrich RJ, Potter JK. Liquid injectable silicone: is there a role as a cosmetic soft-tissue filler?. Plast Reconstr Surg 2004; 113 (04) 1239-1241
    CrossrefPubMedGoogle Scholar
  • 23 Woodward J, Khan T, Martin J. Facial filler complications. Facial Plast Surg Clin North Am 2015; 23 (04) 447-458
    CrossrefPubMedGoogle Scholar
  • 24 Barnett JG, Barnett CR. Treatment of acne scars with liquid silicone injections: 30-year perspective. Dermatol Surg 2005; 31 (11 Pt 2): 1542-1549
    CrossrefPubMedGoogle Scholar
  • 25 Athre RS. Facial filler agents. Oper Tech Otolaryngol 2007; 18: 243-247
    CrossrefPubMedGoogle Scholar
  • 26 Ellis LZ, Cohen JL, High W. Granulomatous reaction to silicone injection. J Clin Aesthet Dermatol 2012; 5 (07) 44-47
    PubMedGoogle Scholar
  • 27 Duffy DM. The silicone conundrum: a battle of anecdotes. Dermatol Surg 2002; 28 (07) 590-594
    PubMedGoogle Scholar
  • 28 Weinkle S, Lupo M. Attitudes, awareness, and usage of medical antiaging treatments: results of a patient survey. J Clin Aesthet Dermatol 2010; 3 (09) 30-33
    PubMedGoogle Scholar
  • 29 Sobanko JF, Dai J, Gelfand JM, Sarwer DB, Percec I. Prospective cohort study investigating changes in body image, quality of life, and self-esteem following minimally invasive cosmetic procedures. Dermatol Surg 2018; 44 (08) 1121-1128
    CrossrefPubMedGoogle Scholar
  • 30 Rkein A, Ozog D, Waibel JS. Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. Dermatol Surg 2014; 40 (06) 624-631
    PubMedGoogle Scholar
  • 31 Nowacki M, Pietkun K, Pokrywczyńska M. , et al. Filling effects, persistence, and safety of dermal fillers formulated with stem cells in an animal model. Aesthet Surg J 2014; 34 (08) 1261-1269
    CrossrefPubMedGoogle Scholar
  • 32 Sclafani AP. Platelet-rich fibrin matrix for improvement of deep nasolabial folds. J Cosmet Dermatol 2010; 9 (01) 66-71
    CrossrefPubMedGoogle Scholar